Home » Medical Devices » Magnetic Resonance Imaging (MRI) Market

Magnetic Resonance Imaging (MRI) Market By Field Strength (Low-field MRI Systems, High-field MRI Systems); By Architecture (Closed MRI Systems, Open MRI Systems); By Application (Neurology, Orthopedics, Cardiology, Oncology); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Report ID: 7815 | Report Format : Excel, PDF

Magnetic Resonance Imaging (MRI) Market Overview:

The Magnetic Resonance Imaging (MRI) market was valued at USD 7094.5 million in 2024 and is anticipated to reach USD 11566.13 million by 2032, growing at a CAGR of 6.3% during the forecast period.

REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
Magnetic Resonance Imaging (MRI) Market Size 2024 USD 7094.5 million
Magnetic Resonance Imaging (MRI) Market, CAGR 6.3%
Magnetic Resonance Imaging (MRI) Market Size 2032 USD 11566.13 million

Magnetic Resonance Imaging (MRI) Market Insights

  • Rising burden of neurological and chronic diseases drives the Magnetic Resonance Imaging market, with high-field MRI systems leading the segment at a 68% share due to superior image quality.
  • Market trends show strong adoption of closed MRI systems, which hold a 72% share, supported by higher field strength and advanced diagnostic capability.
  • Competitive analysis indicates a consolidated Magnetic Resonance Imaging market, where leading players focus on AI integration, faster scan times, and workflow efficiency to strengthen positioning.
  • Regional analysis shows North America leading the Magnetic Resonance Imaging market with a 38% share, followed by Europe at 28% and Asia Pacific at 24%, driven by healthcare infrastructure expansion and imaging demand.

Magnetic Resonance Imaging (MRI) Market Size

Magnetic Resonance Imaging (MRI) Market Segmentation Analysis:

By Field Strength

The By Field Strength segment of the Magnetic Resonance Imaging (MRI) market is dominated by high-field MRI systems, which hold a 68% market share. High-field systems, typically 1.5T and 3T, deliver superior image resolution and faster scan times, making them preferred for complex diagnostic applications. Strong demand from hospitals and diagnostic imaging centers drives adoption. Growth in neurological, cardiac, and oncology imaging further supports this segment. Low-field MRI systems account for the remaining share, supported by lower cost, reduced power requirements, and use in outpatient settings. However, limited image clarity and narrower clinical applications keep low-field systems secondary to high-field MRI solutions.

  • For instance, Hyperfine’s Swoop, operating at 0.064T, supports bedside neuro scans, completing brain exams in 5 minutes, but lacks high-resolution detail needed for advanced diagnoses.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

 

By Architecture

Within the By Architecture segment, closed MRI systems lead the MRI market with a 72% share. Closed systems provide higher magnetic field strength and better image quality, supporting accurate diagnosis across multiple clinical areas. Hospitals favor closed MRI systems for high patient throughput and advanced imaging protocols. Continuous technology upgrades improve patient comfort and scan efficiency. Open MRI systems hold the remaining share, driven by demand for claustrophobic and obese patient imaging. Open designs improve patient experience and accessibility but offer lower field strength, which limits adoption in advanced diagnostic procedures compared to closed MRI systems.

  • For instance, Esaote’s O-Scan system delivers focused musculoskeletal imaging at 0.31T, handling extremity scans in under 12 minutes, but cannot match closed system clarity for whole-body diagnosis.

By Application

The By Application segment is led by neurology, accounting for a 34% share of the Magnetic Resonance Imaging market. MRI remains the gold standard for brain and spinal cord imaging due to high soft-tissue contrast. Rising prevalence of neurological disorders drives strong demand. Oncology follows with significant adoption for tumor detection and staging. Orthopedics benefits from MRI use in joint and musculoskeletal imaging, while cardiology adoption grows with advancements in cardiac MRI techniques. Despite growth across all applications, neurology remains dominant due to diagnostic accuracy requirements and increasing neurological disease burden.

Key Growth Drivers

Rising Burden of Chronic and Neurological Diseases

The growing prevalence of chronic and neurological disorders strongly drives the Magnetic Resonance Imaging market. Conditions such as stroke, brain tumors, epilepsy, and multiple sclerosis require advanced imaging for accurate diagnosis. MRI provides high soft-tissue contrast without radiation exposure. Hospitals increasingly rely on MRI for early disease detection and monitoring. Aging populations further increase scan volumes. Demand rises across neurology, oncology, and cardiology applications. Healthcare systems invest in advanced MRI infrastructure to improve diagnostic accuracy. This driver sustains long-term MRI adoption across developed and emerging regions.

  • For instance, Philips Healthcare reported that its Ingenia Elition 3.0T system completed neurological diffusion scans in under 7 minutes while delivering high spatial resolution, helping clinicians assess stroke cases with greater speed.

Technological Advancements in MRI Systems

Continuous innovation accelerates growth in the Magnetic Resonance Imaging market. Vendors introduce high-field systems with faster scan times and improved image clarity. AI-based software enhances workflow efficiency and diagnostic confidence. Advanced coils and gradient systems improve resolution and reduce noise. Shorter scan durations improve patient comfort and throughput. These advancements expand MRI use in complex clinical cases. Hospitals upgrade existing systems to maintain competitiveness. Technology progress strengthens MRI value across multiple specialties and care settings.

  • For instance, GE HealthCare’s AIR Recon DL reduced noise and boosted image sharpness by up to 60%, while supporting scan time cuts averaging 30% in musculoskeletal exams, helping clinicians make clearer diagnoses.

Expansion of Diagnostic Imaging Infrastructure

Healthcare infrastructure expansion supports Magnetic Resonance Imaging market growth. Governments invest in hospital modernization and diagnostic capacity. Private imaging centers expand to meet rising diagnostic demand. MRI adoption increases in secondary and tertiary care facilities. Public-private partnerships improve access to advanced imaging. Growth in medical tourism further boosts demand. Emerging economies expand imaging services to underserved areas. Infrastructure development ensures wider MRI availability and sustained market expansion.

Key Trends & Opportunities

Growing Adoption of High-Field and Advanced MRI

High-field MRI adoption presents strong opportunities in the market. Providers prefer 1.5T and 3T systems for superior diagnostic performance. Advanced MRI enables functional and diffusion imaging applications. Demand grows for precision diagnostics in oncology and neurology. Research institutions adopt advanced MRI for clinical studies. Premium imaging services support higher reimbursement potential. This trend creates opportunities for system upgrades and premium product offerings.

  • For instance, Siemens Healthineers’ MAGNETOM Vida 3T system uses a 204-channel coil architecture and delivers whole-body diffusion scans in under 11 minutes, supporting high-precision tumor tracking in clinical studies.

Rising Demand for Patient-Centric Imaging Solutions

Patient comfort trends create new opportunities in the Magnetic Resonance Imaging market. Vendors develop quieter systems and wider bore designs. Open and short-bore MRI systems improve patient compliance. Reduced scan anxiety increases procedure completion rates. Pediatric and geriatric imaging benefit from comfort-focused designs. Hospitals differentiate services through patient-friendly imaging solutions. This trend supports broader MRI adoption and service expansion.

  • For instance, Canon Medical’s Vantage Galan 3T system reduces acoustic noise by up to 99% using Pianissimo hardware and delivers a 71 cm bore, helping anxious patients complete full studies without sedation.

Key Challenges

High Cost of MRI Systems and Installation

High capital investment remains a major challenge in the Magnetic Resonance Imaging market. MRI systems require significant upfront spending. Installation demands specialized shielding and infrastructure. Maintenance and service costs add financial pressure. Smaller hospitals face budget constraints. High ownership costs limit adoption in low-income regions. Reimbursement challenges affect return on investment. Cost barriers slow market penetration in price-sensitive healthcare systems.

Shortage of Skilled MRI Professionals

Workforce limitations challenge Magnetic Resonance Imaging market growth. MRI operation requires trained radiologists and technologists. Skill shortages affect scan quality and throughput. Training programs require time and investment. Rural and developing regions face staffing gaps. Workflow inefficiencies increase operational burden. Advanced MRI techniques demand specialized expertise. Addressing talent shortages remains critical for sustained market expansion.

Regional Analysis

North America

North America leads the Magnetic Resonance Imaging market with a 38% market share, driven by advanced healthcare infrastructure and high diagnostic adoption. The United States dominates regional demand due to strong hospital networks and high imaging volumes. Early adoption of high-field MRI systems supports complex neurological and oncology diagnostics. Favorable reimbursement policies encourage technology upgrades. Presence of leading MRI manufacturers strengthens innovation and service support. Rising prevalence of chronic diseases sustains scan demand. Continuous investment in AI-enabled imaging improves workflow efficiency. The region remains the largest contributor due to technology leadership and strong healthcare spending.

Europe

Europe holds a 28% share of the Magnetic Resonance Imaging market, supported by well-established public healthcare systems. Countries such as Germany, France, and the United Kingdom drive demand through widespread diagnostic access. Strong focus on early disease detection supports MRI utilization. Government funding promotes equipment modernization in public hospitals. High adoption in neurology and oncology imaging sustains volumes. Strict quality and safety standards favor advanced MRI systems. Research activity and clinical trials further support demand. Europe maintains steady growth through infrastructure upgrades and emphasis on precision diagnostics.

Asia Pacific

Asia Pacific accounts for a 24% market share in the Magnetic Resonance Imaging market, driven by expanding healthcare infrastructure. China, Japan, and India lead regional adoption due to rising diagnostic demand. Growing population and chronic disease burden increase imaging volumes. Government initiatives improve access to advanced medical imaging. Private diagnostic centers expand rapidly in urban areas. Demand for cost-effective MRI systems supports wider penetration. Medical tourism also contributes to growth. The region shows strong long-term potential due to healthcare investment and rising awareness.

Latin America

Latin America represents a 6% share of the Magnetic Resonance Imaging market, supported by gradual healthcare modernization. Brazil and Mexico lead demand through hospital expansion and private imaging centers. MRI adoption increases for neurology and orthopedic diagnostics. Budget constraints influence system selection and upgrade cycles. Public-private partnerships support diagnostic access improvements. Urban healthcare facilities drive most demand. Growing awareness of early diagnosis supports imaging utilization. Regional growth remains steady but depends on healthcare funding stability and infrastructure development.

Middle East and Africa

The Middle East and Africa hold a 4% share of the Magnetic Resonance Imaging market, reflecting early-stage development. Gulf countries drive demand through investments in advanced hospitals. Medical tourism supports adoption of high-end MRI systems. Public healthcare expansion improves diagnostic access. Africa shows gradual growth due to limited infrastructure and funding constraints. Demand centers on tertiary hospitals and private facilities. Government-led healthcare projects support incremental adoption. Long-term growth depends on infrastructure investment and skilled workforce development.

Magnetic Resonance Imaging (MRI) Market Segmentations:

By Field Strength

  • Low-field MRI systems
  • High-field MRI systems

By Architecture

  • Closed MRI systems
  • Open MRI systems

By Application

  • Neurology
  • Orthopedics
  • Cardiology
  • Oncology

 By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Competitive Landscape

Competitive landscape analysis highlights a consolidated Magnetic Resonance Imaging (MRI) market led by GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Fujifilm Healthcare. These players compete through advanced imaging technology, strong global distribution, and continuous system upgrades. Leading companies focus on high-field MRI systems, AI-enabled software, and workflow automation to improve diagnostic accuracy and throughput. Product portfolios emphasize faster scan times, enhanced image quality, and patient comfort features. Strategic investments in research and development support innovation in functional and cardiac MRI. Partnerships with hospitals and research institutes strengthen clinical adoption. Regional manufacturing and service networks improve installation and after-sales support. Smaller players compete by offering cost-effective and specialty MRI systems. Overall competition centers on technology leadership, clinical performance, service reliability, and long-term customer relationships.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

 

Key Player Analysis

  • GE HealthCare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon Medical Systems Corporation
  • Fujifilm Healthcare
  • Hitachi Medical Systems
  • Esaote S.p.A.
  • United Imaging Healthcare
  • Bruker Corporation
  • Neusoft Medical Systems

Recent Developments

  • In February 2025, Philips introduced its helium-free 1.5T MRI with integrated AI across workflow steps in Europe.
  • In 2025, Siemens Healthineers significantly expanded its MRI portfolio by launching and showcasing systems that heavily integrate AI-enabled imaging and workflow enhancements.
  • In November 2024, GE HealthCare received FDA clearance for its SIGNA™ MAGNUS 3.0T MRI system focused on advanced neuroimaging and research.

Report Coverage

The research report offers an in-depth analysis based on Field Strength, Architecture, Application and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. Demand for Magnetic Resonance Imaging systems will rise with growing chronic disease prevalence.
  2. High-field Magnetic Resonance Imaging systems will remain the preferred technology choice.
  3. Artificial intelligence integration will improve imaging speed and diagnostic accuracy.
  4. Hospitals will continue upgrading Magnetic Resonance Imaging equipment for advanced applications.
  5. Neurology and oncology imaging will drive higher scan volumes.
  6. Patient-centric system designs will gain wider adoption.
  7. Emerging markets will increase investment in Magnetic Resonance Imaging infrastructure.
  8. Service and maintenance offerings will grow in importance for providers.
  9. Workforce training programs will support advanced Magnetic Resonance Imaging usage.
  10. Long-term healthcare investment will sustain Magnetic Resonance Imaging market growth.

Table of Contents (The complete Toc, LoF and LoT are available in the sample report)

1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
3. Executive Summary
4. Introduction
4.1. Overview
4.2. Key Industry Trends
5. Global Magnetic Resonance Imaging (MRI) Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
6. Market Breakup by Field Strength
6.1. Low-Field MRI Systems
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. High-Field MRI Systems
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity
7. Market Breakup by Architecture
7.1. Closed MRI Systems
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Open MRI Systems
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
8. Market Breakup by Application
8.1. Neurology
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Orthopedics
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
8.3. Cardiology
8.3.1. Market Trends
8.3.2. Market Forecast
8.3.3. Revenue Share
8.3.4. Revenue Growth Opportunity
8.4. Oncology
8.4.1. Market Trends
8.4.2. Market Forecast
8.4.3. Revenue Share
8.4.4. Revenue Growth Opportunity
9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats
11. Value Chain Analysis
12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
13. Price Analysis
14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. GE HealthCare
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Siemens Healthineers
14.3.3. Philips Healthcare
14.3.4. Canon Medical Systems Corporation
14.3.5. Fujifilm Healthcare
14.3.6. Hitachi Medical Systems
14.3.7. Esaote S.p.A.
14.3.8. United Imaging Healthcare
14.3.9. Bruker Corporation
14.3.10. Neusoft Medical Systems
15. Research Methodology

Request Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices


Providing the strategic compass for industry titans.

cr-clients-logos

Frequently Asked Questions

What is the current market size for Magnetic Resonance Imaging (MRI) market, and what is its projected size in 2032?

The Magnetic Resonance Imaging (MRI) market reached USD 7094.5 million in 2024 and is projected to reach USD 11566.13 million by 2032.

At what Compound Annual Growth Rate is the Magnetic Resonance Imaging (MRI) market projected to grow between 2024 and 2032?

The Magnetic Resonance Imaging (MRI) market is projected to grow at a CAGR of 6.3% during 2024–2032.

Which Magnetic Resonance Imaging (MRI) market segment held the largest share in 2024?

High-field systems led the Magnetic Resonance Imaging (MRI) market in 2024 with a 68% share.

What are the primary factors fueling the growth of the Magnetic Resonance Imaging (MRI) market?

Chronic disease burden, technology advances, and imaging infrastructure expansion fuel the Magnetic Resonance Imaging (MRI) market.

Who are the leading companies in the Magnetic Resonance Imaging (MRI) market?

Leading Magnetic Resonance Imaging (MRI) market players include GE HealthCare, Siemens Healthineers, Philips Healthcare, and Canon Medical.

Which region commanded the largest share of the Magnetic Resonance Imaging (MRI) market in 2024?

North America led the Magnetic Resonance Imaging (MRI) market in 2024 with a 38% share.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Cell Cytometry Market

Cell Cytometry market size was valued USD 5,659 Million in 2024 and is anticipated to reach USD 10,319.51 Million by 2032, at a CAGR of 7.8% during the forecast period.

Blood Meal Market

Blood Meal Market size was valued USD 8,920 Million in 2024 and is anticipated to reach USD 14,542.23 Million by 2032, at a CAGR of 6.3% during the forecast period.

Audiology Devices Market

The Audiology Devices market size reached USD 14,763 million in 2024. It is expected to reach USD 23,655.31 million by 2032, at a CAGR of 6.07% during the forecast period.

Diagnostic Specialty Antibodies Market

The diagnostic specialty antibodies market was valued at USD 4,093 million in 2024 and is projected to reach USD 7,860.6 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.5% during the forecast period.

Novel Spectrometry Platforms Market

Novel Spectrometry Platforms Market size was valued USD 2219 million in 2024 and is anticipated to reach USD 3430.76 million by 2032, at a CAGR of 5.6% during the forecast period.

Coronary Microcatheters Market

Coronary Microcatheters Market size was valued USD 2180 million in 2024 and is anticipated to reach USD 3100.18 million by 2032, at a CAGR of 4.5% during the forecast period.

Disability Devices Market

The Disability Devices Market size was estimated at USD 21,480.60 million in 2025 and is expected to reach USD 33,935.80 million by 2032, growing at a CAGR of 7.92% from 2025 to 2032.

Disposable Gloves Market

The Global Disposable Gloves Market is projected to grow from USD18,873.30 million in 2024 to an estimated USD34,973.61 million based on 2032, with a compound annual growth rate (CAGR) of 8.08% from 2025 to 2032.

Disposable Medical Sensors Market

The Disposable Medical Devices Sensors Market size was estimated at USD 4,860.25 million in 2025 and is expected to reach USD 9,926.92 million by 2032, growing at a CAGR of 12.64% from 2025 to 2032.

Home Rehabilitation Products and Services Market

The home rehabilitation products and services market size was valued at USD 99,942.46 million in 2024 and is expected to reach USD 167,905.7 million by 2032, registering a CAGR of 6.7% during the forecast period.

mRNA Vaccine and Therapeutics Market

The Global mRNA Vaccine and Therapeutics Market size was valued at USD 7,800.00 million in 2018 to USD 13,444.94 million in 2024 and is anticipated to reach USD 46,668.48 million by 2032, at a CAGR of 16.93% during the forecast period.

Orthopedic Oncology Treatment Market

Orthopedic Oncology Treatment Market size was valued USD 1310 million in 2024 and is anticipated to reach USD 2135.79 million by 2032, at a CAGR of 6.3% during the forecast period.

Licence Option

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Europe

North America

Email

Smallform of Sample request
User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

cr-clients-logos

Request Sample